✦ LIBER ✦

Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial

✍ Scribed by Hidemi NAKAGAWA; Brad SCHENKEL; Mai KATO; Takeshi KATO; Atsuyuki IGARASHI; The Japanese Ustekinumab Study Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ustekinumab significantly improves sympt

✍ Richard G. Langley; Steven R. Feldman; Chenglong Han; Brad Schenkel; Philippe Sz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Efficacy and safety of ustekinumab in Ja

✍ Atsuyuki IGARASHI; Takeshi KATO; Mai KATO; Michael SONG; Hidemi NAKAGAWA; THE JA 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB

Impact of adalimumab treatment on health

✍ D. Revicki; M.K. Willian; J.-H. Saurat; K.A. Papp; J.-P. Ortonne; C. Sexton; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Patient-reported outcomes in moderate-to

✍ S. Tyring; J. Bagel; C. Lynde; P. Klekotka; E.H.Z. Thompson; S.R. Gandra; Y. Shi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Efficacy and safety of topical WBI-1001

✍ R. Bissonnette; C. Bolduc; C. Maari; S. Nigen; J.M. Webster; L. Tang; M. Lyle 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

Safety and efficacy (PASI 90 and global

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB